news
Researchers identified a potential therapeutic involving the inhibition of PIP4K…
27 July 2021 | By Anna Begley (Drug Target Review)
Researchers identified a potential therapeutic involving the inhibition of PIP4K enzymes which could enable the immune system to destroy tumour cells.